Search

All radiotherapy treatments for prostate cancer should be accompanied by image-guidance of the prostate position to rule out significant setup errors in fractional delivery.

… Monday, November 19, 2018 All radiotherapy treatments for prostate cancer should be accompanied by image-guidance of the prostate position to rule out significant setup errors in fractional delivery. The results of our most recent analysis of planning data for 102 patients treated consecutively at Memorial

Memorial Sloan Kettering's Boards of Overseers and Managers have announced the creation of the Bristol-Myers Squibb/James D. Robinson III Junior Faculty Chairs and have named the first two incumbents: Sloan Kettering Institute's Grégoire Altan-Bonnet and Songhai Shi.

… Wednesday, July 1, 2009 Summary Memorial Sloan Kettering’s Boards of Overseers and Managers have announced the creation of the Bristol-Myers Squibb/James D. Robinson III Junior Faculty Chairs and have named the first two incumbents: Sloan Kettering Institute’s Grégoire Altan-Bonnet and Songhai Shi. Memorial

James Rothman, who receives this year’s Nobel Prize in Physiology or Medicine together with Randy Schekman and Thomas Südhof, conducted more than a decade of his seminal research at Memorial Sloan Kettering.

… Monday, October 14, 2013 Summary James Rothman, who receives this year’s Nobel Prize in Physiology or Medicine together with Randy Schekman and Thomas Südhof, conducted more than a decade of his seminal research at Memorial Sloan Kettering. Last week James E. Rothman, Randy W. Schekman, and Thomas C.

Meet Mary Wu, a patient financial services specialist at Memorial Sloan Kettering Westchester.

… Tuesday, May 17, 2022 Mary Wu remembers the 2012 Rose Parade like it was yesterday. The roar of the spectators lining Colorado Boulevard as each float came into view. The warmth of the New Year’s Day sun. Her perch atop the Donate Life Float . “I can’t put it into words,” says Mary, a patient financial

MSK researchers have found that a genetic state in tumors called whole-genome doubling is connected with worse outcomes for people with cancer.

… Wednesday, July 18, 2018 Summary MSK-IMPACT™ has led to many important findings about cancer genomics. In a recent study, researchers found that a genetic state in tumors called whole-genome doubling is connected with worse outcomes for people with cancer. Healthy cells contain two copies of each gene

New research on an experimental drug provides hope for better responses to immunotherapy.

… Wednesday, November 9, 2016 Summary Despite the promise of immunotherapy for cancer, not everyone responds. Researchers at MSK are testing a new drug that can overcome a tumor’s resistance to immunotherapy. Highlights Many tumors contain immune-suppressive cells that make them resistant to immunotherapy

Memorial Sloan Kettering Cancer Center will recognize three young investigators for their exceptional bodies of innovative work that has helped to advance the field of cancer research. The researchers will receive the Paul Marks Prize for Cancer Research, an award presented biennially by Memorial Sloan Kettering to honor promising scientists under the age of 46.

… Tuesday, September 20, 2011 Memorial Sloan Kettering Cancer Center will recognize three young investigators for their exceptional bodies of innovative work that has helped to advance the field of cancer research. The researchers will receive the Paul Marks Prize for Cancer Research, an award presented

Uniting MSK’s research and clinical expertise with AWS’s advanced cloud technologies is a bold step towards addressing one of the world’s most pressing health challenges.

… Monday, March 10, 2025 Amazon Web Services (AWS), an Amazon.com, Inc. company (NASDAQ: AMZN) and Memorial Sloan Kettering Cancer Center (MSK), a leading global cancer center, today announced a collaboration harnessing the power of artificial intelligence (AI), high performance computing (HPC), and other

Memorial Sloan Kettering Cancer Center (MSK) announces its most recent awards and appointments for the institution’s physicians, scientists, nurses, and staff.

… Wednesday, September 16, 2020 Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and appointments: Forbes Names Memorial Sloan Kettering Cancer Center #2 Best Employer in New York State Memorial Sloan Kettering Cancer Center MSK was named the second-best employer in New York

The May 4 session of “MSK Science Spotlight” will feature series host, Andrea Schietinger, PhD, Assistant Member, Immunology Program, SKI, presenting her own research, “Decoding T Cell Dysfunction in Tumors.” Dr. Schietinger, a former winner of the prestigious National Institutes of Health Director’s New Innovator Award, has served as host for past sessions of the online seminar series for the scientific community.

… Monday, May 4, 2020 The May 4 session of “MSK Science Spotlight” will feature series host, Andrea Schietinger, PhD , Assistant Member, Immunology Program, SKI, presenting her own research, “Decoding T Cell Dysfunction in Tumors.” Dr. Schietinger, a former winner of the prestigious National Institutes